Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Avicenna Journal of Medicine|November 25, 2024
Treatment of a Large Gluteal Hydatid Cyst in Syria Using a Manual Negative Pressure Wound Therapy Device (PragmaVAC)M Netfagi, H Alshaer, A Abbara, et al.
Public Health|August 4, 2018
Cross-sectional growth assessment of children in four refugee camps in Northern GreeceS C Walpole, A Abbara, M Gunst, et al.
Health Policy (Amsterdam, Netherlands)|June 24, 2019
Healthcare access for refugees in Greece: Challenges and opportunitiesM Gunst, K Jarman, V Yarwood, et al.
Medicine, Conflict, and Survival|April 30, 2024
Respiratory health and the Syrian conflict: a scoping literature reviewL Basha, M Hamze, A Socarras, et al.
Clinical Endocrinology|March 5, 2013
A single injection of kisspeptin-54 temporarily increases luteinizing hormone pulsatility in healthy womenC N Jayasena, A N Comninos, J D Veldhuis, et al.
Human Reproduction (Oxford, England)|December 6, 2017
The direct and indirect effects of kisspeptin-54 on granulosa lutein cell functionL A Owens, A Abbara, A Lerner, et al.
Human Reproduction (Oxford, England)|June 20, 2015
Direct comparison of the effects of intravenous kisspeptin-10, kisspeptin-54 and GnRH on gonadotrophin secretion in healthy menC N Jayasena, A Abbara, S Narayanaswamy, et al.
Clinical Endocrinology|February 16, 2018
Clinical parameters of ovarian hyperstimulation syndrome following different hormonal triggers of oocyte maturation in IVF treatmentA Abbara, R Islam, S A Clarke, et al.
Clinical Pharmacology and Therapeutics|October 29, 2010
Twice-weekly administration of kisspeptin-54 for 8 weeks stimulates release of reproductive hormones in women with hypothalamic amenorrheaC N Jayasena, G M K Nijher, A Abbara, et al.
The Journal of Clinical Endocrinology and Metabolism|September 14, 2013
Twice-daily subcutaneous injection of kisspeptin-54 does not abolish menstrual cyclicity in healthy female volunteersC N Jayasena, A N Comninos, G M K Nijher, et al.
Pageof 2